JNJ-42165279
CAS No. 1346528-50-4
JNJ-42165279( JNJ42165279 | JNJ 42165279 )
Catalog No. M11398 CAS No. 1346528-50-4
JNJ-42165279 is a highly selective inhibitor of fatty acid amide hydrolase (FAAH) with IC50 of 70 nM for hFAAH.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 58 | In Stock |
|
| 5MG | 91 | In Stock |
|
| 10MG | 135 | In Stock |
|
| 25MG | 259 | In Stock |
|
| 50MG | 389 | In Stock |
|
| 100MG | 572 | In Stock |
|
| 200MG | 808 | In Stock |
|
| 500MG | 1215 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-42165279
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-42165279 is a highly selective inhibitor of fatty acid amide hydrolase (FAAH) with IC50 of 70 nM for hFAAH.
-
DescriptionJNJ-42165279 is a highly selective inhibitor of fatty acid amide hydrolase (FAAH) with IC50 of 70 nM for hFAAH; no inhibition on CYPs and hERG at 10 uM; blocks FAAH in the brain and periphery of rats , causes an elevation of the concentrations of AEA, OEA, and PEA; demonstrates activity in the spinal nerve ligation (SNL) model of neuropathic pain; exhibited excellent ADME and pharmacodynamic properties.Anxiety Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsJNJ42165279 | JNJ 42165279
-
PathwayMetabolic Enzyme/Protease
-
TargetFAAH
-
RecptorhFAAH|rFAAH
-
Research AreaNeurological Disease
-
IndicationAnxiety
Chemical Information
-
CAS Number1346528-50-4
-
Formula Weight410.8024
-
Molecular FormulaC18H17ClF2N4O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl
-
Chemical Name1-Piperazinecarboxamide, N-(4-chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Keith JM, et al. ACS Med Chem Lett. 2015 Nov 2;6(12):1204-8.
molnova catalog
related products
-
VU534
VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism.
-
ASP 8477
A novel potent, highly selective fatty acid amide hydrolase (FAAH) inhibitor with IC50 of 0.99, 1.65 and 57.3 nM for human FAAH-1, FAAH-1 (P129T) and FAAH-2, respectively.
-
FAAH inhibitor 1
FAAH inhibitor 1 is an effective FAAH inhibitor with an IC50 of 18 nM.
Cart
sales@molnova.com